With increasing age, the ability of the immune system to protect against new antigenic challenges or to control chronic infections erodes. One of the immediate implications of immunosenescence is a decline in the response to prophylactic vaccinations increasing the susceptibility to viral and bacterial infections. Our studies have shown that the mechanisms underlying the defective adaptive immune response change with age. After the age of 75 years, the naTve CD4 T cell compartment is small and its diversity is severely contracted, essentially abating the ability to mount a T cell response to new vaccines. Before that age, the repertoire diversity of the naTve CD4 compartment is intact, and we postulate that cell-intrinsic defects compromise immunity. Compared to young adults, we have identified two signatures that are characteristic of naTve CD4 T cell responses in 60 to 74 year-old healthy individuals, failed induction of type I interferon-stimulated genes (ISG) in CD4 T cells and sustained increases in cytoplasmic zinc that leads to the overinduction of metallothioneins, further dysregulation of cytoplasmic zinc homeostasis and changes in the cellular redox state. In contrast to CD4 T cells, naTve CD8 T cells disappear more rapidly and CD8 memory T cells develop a signature dominated by the expression of negative regulatory receptors. In the current application, we propose to examine the mechanisms underlying these signatures as well as their implications for T cell differentiation and function. We use in vitro systems with T cells from individuals of different ages and an in vivo system of individuals undergoing yellow fever vaccination.
In Specific Aim 1, we will examine the hypothesis that a defect in interferon signaling is responsible for the failure to induce ISG. We will use gene profiling to determine the role of interferon stimulation in T cell differentiation, and we will explore stimulation condition to minimize this defect.
In Specific Aim 2, we will determine the impact of the age dependent zinc-MT signature on naive CD4 T cell responses and examine whether the change in cytoplasmic zinc homeostasis is amenable to stimulation conditions.
Specific Aim 3 will examine the hypothesis that the transcription of negative regulatory receptors is epigenetically controlled and that their increased expression with age relates to global DMA CpG demethylation.

Public Health Relevance

With increasing age, vaccine responses decline, and vaccinations are only partially protective or not protective at all. A decrease in vaccination success rates is already evident in the 6th and 7th decade of life. In addition, vaccinations with live viruses are associated with increased side effects. With the changing demographics of the US population, this decline in immune competence is a major health problem. An understanding of the immune aging process is necessary to improve the strategies whom and when to vaccinate and to identify means to improve vaccine responses in the elderly.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI057266-10
Application #
8468622
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
10
Fiscal Year
2013
Total Cost
$398,422
Indirect Cost
$82,507
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Fang, Fengqin; Yu, Mingcan; Cavanagh, Mary M et al. (2016) Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals. Cell Rep 14:1218-31
Ravindran, Rajesh; Loebbermann, Jens; Nakaya, Helder I et al. (2016) The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature 531:523-7
Chandele, Anmol; Sewatanon, Jaturong; Gunisetty, Sivaram et al. (2016) Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol 90:11259-11278
Neu, Karlynn E; Henry Dunand, Carole J; Wilson, Patrick C (2016) Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease? Curr Opin Immunol 42:48-55
DiLillo, David J; Palese, Peter; Wilson, Patrick C et al. (2016) Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J Clin Invest 126:605-10
Henry Dunand, Carole J; Leon, Paul E; Huang, Min et al. (2016) Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host Microbe 19:800-13
Qi, Qian; Cavanagh, Mary M; Le Saux, Sabine et al. (2016) Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med 8:332ra46
Ho, Irvin Y; Bunker, Jeffrey J; Erickson, Steven A et al. (2016) Refined protocol for generating monoclonal antibodies from single human and murine B cells. J Immunol Methods 438:67-70
Nakaya, Helder I; Clutterbuck, Elizabeth; Kazmin, Dmitri et al. (2016) Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A 113:1853-8
Burke, Rachel M; Suchdev, Parminder S; Rebolledo, Paulina A et al. (2016) Predictors of Inflammation in a Cohort of Bolivian Infants and Toddlers. Am J Trop Med Hyg 95:954-963

Showing the most recent 10 out of 202 publications